Cargando…
Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome
A 32-year-old woman undergoing an in vitro fertilization program was admitted to our hospital with the diagnosis of severe ovarian hyperstimulation syndrome (OHSS). Transvaginal ultrasonography showed two gestational sacs. Treatment with fluid restriction, serum albumin and intravenous furosemide wa...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822664/ https://www.ncbi.nlm.nih.gov/pubmed/31742201 http://dx.doi.org/10.12890/2019_001253 |
_version_ | 1783464379817132032 |
---|---|
author | Gómez, Gemma Grau Campanario, Oriol Giménez Serra, Nuria Pons Llobell, Mireia Cairó Mena, Pedro Almagro |
author_facet | Gómez, Gemma Grau Campanario, Oriol Giménez Serra, Nuria Pons Llobell, Mireia Cairó Mena, Pedro Almagro |
author_sort | Gómez, Gemma Grau |
collection | PubMed |
description | A 32-year-old woman undergoing an in vitro fertilization program was admitted to our hospital with the diagnosis of severe ovarian hyperstimulation syndrome (OHSS). Transvaginal ultrasonography showed two gestational sacs. Treatment with fluid restriction, serum albumin and intravenous furosemide was started, and repeated thoracentesis and paracenteses were performed. In the absence of clinical improvement, the patient was transferred to the intensive care unit and a therapeutic abortion was suggested. Due to the similarities between OHSS and idiopathic systemic capillary leak syndrome, we offered the patient compassionate treatment with intravenous immunoglobulins. After administration, the patient showed rapid improvement and we were able to suspend intravenous furosemide and serum albumin. She was discharged, and pregnancy has continued normally to date. LEARNING POINTS: OHSS is an infrequent yet serious complication of assisted reproductive treatment that involves increased capillary permeability. In severe refractory cases, immunoglobulins may be a useful and safe treatment to reverse this syndrome. |
format | Online Article Text |
id | pubmed-6822664 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SMC Media Srl |
record_format | MEDLINE/PubMed |
spelling | pubmed-68226642019-11-18 Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome Gómez, Gemma Grau Campanario, Oriol Giménez Serra, Nuria Pons Llobell, Mireia Cairó Mena, Pedro Almagro Eur J Case Rep Intern Med Articles A 32-year-old woman undergoing an in vitro fertilization program was admitted to our hospital with the diagnosis of severe ovarian hyperstimulation syndrome (OHSS). Transvaginal ultrasonography showed two gestational sacs. Treatment with fluid restriction, serum albumin and intravenous furosemide was started, and repeated thoracentesis and paracenteses were performed. In the absence of clinical improvement, the patient was transferred to the intensive care unit and a therapeutic abortion was suggested. Due to the similarities between OHSS and idiopathic systemic capillary leak syndrome, we offered the patient compassionate treatment with intravenous immunoglobulins. After administration, the patient showed rapid improvement and we were able to suspend intravenous furosemide and serum albumin. She was discharged, and pregnancy has continued normally to date. LEARNING POINTS: OHSS is an infrequent yet serious complication of assisted reproductive treatment that involves increased capillary permeability. In severe refractory cases, immunoglobulins may be a useful and safe treatment to reverse this syndrome. SMC Media Srl 2019-10-02 /pmc/articles/PMC6822664/ /pubmed/31742201 http://dx.doi.org/10.12890/2019_001253 Text en © EFIM 2019 This article is licensed under a Commons Attribution Non-Commercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | Articles Gómez, Gemma Grau Campanario, Oriol Giménez Serra, Nuria Pons Llobell, Mireia Cairó Mena, Pedro Almagro Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome |
title | Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome |
title_full | Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome |
title_fullStr | Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome |
title_full_unstemmed | Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome |
title_short | Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome |
title_sort | immunoglobulin treatment in severe ovarian hyperstimulation syndrome |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822664/ https://www.ncbi.nlm.nih.gov/pubmed/31742201 http://dx.doi.org/10.12890/2019_001253 |
work_keys_str_mv | AT gomezgemmagrau immunoglobulintreatmentinsevereovarianhyperstimulationsyndrome AT campanariooriolgimenez immunoglobulintreatmentinsevereovarianhyperstimulationsyndrome AT serranuriapons immunoglobulintreatmentinsevereovarianhyperstimulationsyndrome AT llobellmireiacairo immunoglobulintreatmentinsevereovarianhyperstimulationsyndrome AT menapedroalmagro immunoglobulintreatmentinsevereovarianhyperstimulationsyndrome |